Washington, DC, October 26, 2021
A new Marketing for Change poll, with data collected by Ipsos, explores attitudes among parents towards vaccinating their children against COVID-19. When thinking about getting their kids vaccinated, parents of children age 5-11 most often consider vaccine side effects (48%), protecting their child(ren) from getting sick with COVID-19 (40%), and their child(ren)'s ability to participate in school and community activities that may require the vaccine (36%). Methodological details about the study are below, and the list of questions are attached.
For the Marketing for Change release, please click here.
About the Study
These are the findings of a Marketing for Change poll, with data collected by Ipsos, conducted between October 14-22, 2021. For this survey, a sample of 1,019 adults age 18+ from the continental U.S., Alaska, and Hawaii who are parents of children under 18 was interviewed online in English.
The sample was randomly drawn from Ipsos’ online panel, partner online panel sources, and “river” sampling and does not rely on a population frame in the traditional sense. Ipsos uses fixed sample targets, unique to each study, in drawing a sample. After a sample has been obtained from the Ipsos panel, Ipsos calibrates respondent characteristics to be representative of the U.S. Population using standard procedures such as raking-ratio adjustments. The source of these population targets is U.S. Census 2018 American Community Survey data. The sample drawn for this study reflects fixed sample targets on demographics. Posthoc weights were made to the population characteristics on gender, age, race/ethnicity, region, and education.
Statistical margins of error are not applicable to online non-probability polls. All sample surveys and polls may be subject to other sources of error, including, but not limited to coverage error and measurement error. Where figures do not sum to 100, this is due to the effects of rounding. The precision of Ipsos online polls is measured using a credibility interval. In this case, the poll has a credibility interval of plus or minus 3.5 percentage points for all respondents. Ipsos calculates a design effect (DEFF) for each study based on the variation of the weights, following the formula of Kish (1965). This study had a credibility interval adjusted for design effect of the following (n=1,019, DEFF=1.5, adjusted Confidence Interval=+/-5.0 percentage points).
For more information on this news release, please contact:
Senior Vice President, U.S., Public Affairs
+1 202 420-2025
Media Relations Specialist, U.S., Public Affairs
+1 718 755-8829
Ipsos is the world’s third largest Insights and Analytics company, present in 90 markets and employing more than 18,000 people.
Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. We serve more than 5000 clients across the world with 75 business solutions.
Founded in France in 1975, Ipsos is listed on the Euronext Paris since July 1st, 1999. The company is part of the SBF 120 and the Mid-60 index and is eligible for the Deferred Settlement Service (SRD).
ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP www.ipsos.com